UK markets closed

Aclaris Therapeutics, Inc. (0H8T.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
1.3620+0.0833 (+6.51%)
At close: 05:54PM BST

Insider roster

Individual or entityMost-recent transactionDateShares owned as of transaction date

BALTHASER KEVIN J
Chief Financial Officer

Conversion of Exercise of derivative security

01 Mar 2024

23,983

CAWKWELL GAIL
Officer

Conversion of Exercise of derivative security

30 Jun 2023

9,593

LOEROP JAMES
Officer

Conversion of Exercise of derivative security

01 Feb 2024

34,017

MANION DOUGLAS J
Chief Executive Officer

Conversion of Exercise of derivative security

29 Dec 2023

41,813

MILANO VINCENT J
Director

Conversion of Exercise of derivative security

02 Jun 2023

7,863

MOLINEAUX CHRISTOPHER P
Director

Conversion of Exercise of derivative security

20 Jun 2023

48,503

MONAHAN JOSEPH B
Officer

Conversion of Exercise of derivative security

01 Mar 2024

186,976

POWELL ANDREW KENNETH WILLIAM
Director

Purchase

04 Mar 2024

28,863

SCHIFF ANDREW N
Director

Conversion of Exercise of derivative security

02 Jun 2023

438,962

WALKER NEAL
Chief Executive Officer

Conversion of Exercise of derivative security

01 May 2024

1,292,370

*Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.